sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Asia Pacific Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity

Asia Pacific Point of Care (PoC) Molecular Diagnostics Market 2020-2030...

Home / Categories / Healthcare
Asia Pacific Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity
Asia Pacific Point of Care...
Report Code
RO1/105/1053

Publish Date
28/Sep/2020

Pages
124
PRICE
$ 2900/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 3900/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 5000/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Asia Pacific PoC molecular diagnostics market will grow by 15.1% annually with a total addressable market cap of $8,360.1 million over 2020-2030 owing to the rising adoption of PoC molecular diagnostics for drug discovery and development amid COVID-19 pandemic.
Highlighted with 34 tables and 52 figures, this 124-page report Asia Pacific Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Asia Pacific PoC molecular diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porters Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific PoC molecular diagnostics market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Kits & Assays
- Analyzers & Instruments
- Software & Services

Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Polymerase Chain Reaction (PCR)
- Real-Time PCR (rt-PCR)
- Digital PCR (d-PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Genetic Sequencing-based Technology
Microarray-based Technology
Other Technologies

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Infectious Disease
- Respiratory Infections
- Hospital Acquired Infections
- Sexually Transmitted Infections
Gastrointestinal Infections
Oncology
Hepatitis
Prenatal/Neonatal Testing
Other Applications

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Hospitals
- Clinics & Diagnostic Centers
- Research and Academic Institutes
- Other End Users

Geographically, the following national/local markets are fully investigated:
- Japan
- China
- South Korea
- Australia
- India
- Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
Detailed analysis and 2019-2030 annual revenue are available for each key national market. The breakdown of key national markets by Product, Technology, and Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific PoC molecular diagnostics market are assayed quantitatively and qualitatively through GMDs Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abacus Diagnostica Oy
Abbott Laboratories
Alere Inc.
Biocartis Group NV
Biomerieux SA
Bio-Rad Laboratories Inc
Danaher Corporation
DiaSorin S.p.A
DxNA LLC.
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Luminex Corporation
Meridian Bioscience Inc.
Mesa Biotech Inc.
QIAGEN N.V.
QuantuMDx Group Ltd.
Quidel Corporation
Spartan Biosciences Inc.
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com